Kuwait · Delayed Price · Currency is KWD · Price in KWF KWSE:NIH Statistics
Total Valuation
KWSE:NIH has a market cap or net worth of KWD 38.07 million. The enterprise value is 42.78 million.
| Market Cap | 38.07M |
| Enterprise Value | 42.78M |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KWSE:NIH has 245.64 million shares outstanding. The number of shares has increased by 1.16% in one year.
| Current Share Class | 245.64M |
| Shares Outstanding | 245.64M |
| Shares Change (YoY) | +1.16% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 6.55% |
| Owned by Institutions (%) | n/a |
| Float | 154.24M |
Valuation Ratios
The trailing PE ratio is 15.06.
| PE Ratio | 15.06 |
| Forward PE | n/a |
| PS Ratio | 4.17 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | 32.55 |
| P/OCF Ratio | 30.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.21, with an EV/FCF ratio of 36.57.
| EV / Earnings | 16.85 |
| EV / Sales | 4.69 |
| EV / EBITDA | 9.21 |
| EV / EBIT | 9.63 |
| EV / FCF | 36.57 |
Financial Position
The company has a current ratio of 6.72, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.72 |
| Quick Ratio | 4.80 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | 1.95 |
| Interest Coverage | 18.26 |
Financial Efficiency
Return on equity (ROE) is 5.45% and return on invested capital (ROIC) is 5.44%.
| Return on Equity (ROE) | 5.45% |
| Return on Assets (ROA) | 4.95% |
| Return on Invested Capital (ROIC) | 5.44% |
| Return on Capital Employed (ROCE) | 7.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.16 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, KWSE:NIH has paid 17,805 in taxes.
| Income Tax | 17,805 |
| Effective Tax Rate | 0.67% |
Stock Price Statistics
The stock price has decreased by -0.60% in the last 52 weeks. The beta is 0.14, so KWSE:NIH's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -0.60% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.17 |
| Relative Strength Index (RSI) | 74.36 |
| Average Volume (20 Days) | 4,113,825 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KWSE:NIH had revenue of KWD 9.12 million and earned 2.54 million in profits. Earnings per share was 0.01.
| Revenue | 9.12M |
| Gross Profit | 6.16M |
| Operating Income | 4.44M |
| Pretax Income | 2.67M |
| Net Income | 2.54M |
| EBITDA | 4.64M |
| EBIT | 4.44M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 6.99 million in cash and 2.28 million in debt, giving a net cash position of 4.71 million or 0.02 per share.
| Cash & Cash Equivalents | 6.99M |
| Total Debt | 2.28M |
| Net Cash | 4.71M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 51.21M |
| Book Value Per Share | 0.17 |
| Working Capital | 10.60M |
Cash Flow
In the last 12 months, operating cash flow was 1.24 million and capital expenditures -73,430, giving a free cash flow of 1.17 million.
| Operating Cash Flow | 1.24M |
| Capital Expenditures | -73,430 |
| Free Cash Flow | 1.17M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 67.53%, with operating and profit margins of 48.70% and 27.84%.
| Gross Margin | 67.53% |
| Operating Margin | 48.70% |
| Pretax Margin | 29.24% |
| Profit Margin | 27.84% |
| EBITDA Margin | 50.91% |
| EBIT Margin | 48.70% |
| FCF Margin | 12.82% |
Dividends & Yields
KWSE:NIH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 52.13% |
| Buyback Yield | -1.16% |
| Shareholder Yield | n/a |
| Earnings Yield | 6.67% |
| FCF Yield | 3.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 5, 2025. It was a forward split with a ratio of 1.06.
| Last Split Date | Aug 5, 2025 |
| Split Type | Forward |
| Split Ratio | 1.06 |
Scores
KWSE:NIH has an Altman Z-Score of 4.8 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.8 |
| Piotroski F-Score | 6 |